• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.

作者信息

Valls Laia, Hoimes Christopher, Sher Andrew, Hu Lingzhi, Lee Zhenghong, Muzic Raymond, Avril Norbert

机构信息

Department of Radiology, University Hospitals Case Medical Center, Case Center for Imaging Research, Case Western Reserve University, Cleveland, OH.

Department of Medicine, University Hospitals Case Medical Center, Case Center for Imaging Research, Case Western Reserve University, Cleveland, OH.

出版信息

Semin Roentgenol. 2014 Jul;49(3):238-41. doi: 10.1053/j.ro.2014.09.001. Epub 2014 Sep 16.

DOI:10.1053/j.ro.2014.09.001
PMID:25497908
Abstract
摘要

相似文献

1
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.使用[F-18]氟代胸苷-正电子发射断层扫描-磁共振对转移性肾细胞癌中受体酪氨酸激酶抑制剂治疗进行早期反应监测
Semin Roentgenol. 2014 Jul;49(3):238-41. doi: 10.1053/j.ro.2014.09.001. Epub 2014 Sep 16.
2
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.舒尼替尼治疗转移性肾细胞癌患者的正电子发射断层扫描/计算机断层扫描联合评估。
Clin Oncol (R Coll Radiol). 2011 Jun;23(5):339-43. doi: 10.1016/j.clon.2010.11.006. Epub 2010 Dec 4.
3
FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma.采用氟代脱氧葡萄糖（FDG）和氟代胸苷（FLT）正电子发射断层扫描（PET）对转移性肾细胞癌患者每日37.5毫克舒尼替尼治疗的早期反应进行测量
Cancer Imaging. 2015 Sep 3;15(1):15. doi: 10.1186/s40644-015-0049-x.
4
The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response.多靶点受体酪氨酸激酶治疗后原发性肾细胞癌肿瘤的放射性增强丧失是反应的另一个指标。
Urology. 2010 May;75(5):1108-13.e1. doi: 10.1016/j.urology.2009.06.105. Epub 2009 Nov 20.
5
Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib.在接受舒尼替尼治疗的转移性肾细胞癌中，肺动脉血栓形成酷似疾病进展。
Indian J Cancer. 2016 Jan-Mar;53(1):112-3. doi: 10.4103/0019-509X.180852.
6
Long-term response with sunitinib for metastatic renal cell carcinoma.舒尼替尼治疗转移性肾细胞癌的长期疗效。
Urology. 2006 Sep;68(3):672.e19-20. doi: 10.1016/j.urology.2006.03.042. Epub 2006 Sep 18.
7
Sunitinib in patients with metastatic renal cell carcinoma.舒尼替尼用于转移性肾细胞癌患者。
JAMA. 2006 Jun 7;295(21):2516-24. doi: 10.1001/jama.295.21.2516.
8
Sunitinib (SUTENT) for the treatment of metastatic renal cell carcinoma.舒尼替尼（索坦）用于治疗转移性肾细胞癌。
Expert Rev Anticancer Ther. 2008 Nov;8(11):1723-31. doi: 10.1586/14737140.ahead-of-print.
9
18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study.18F-FDG PET/CT成像用于转移性肾癌中舒尼替尼治疗反应的早期评估：初步研究
Cancer Biother Radiopharm. 2009 Feb;24(1):137-44. doi: 10.1089/cbr.2008.0527.
10
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma.11C-乙酸盐正电子发射断层扫描用于转移性肾细胞癌中舒尼替尼反应的早期预测
Tumori. 2009 May-Jun;95(3):382-4. doi: 10.1177/030089160909500320.

引用本文的文献

1
Non-invasive molecular imaging of kidney diseases.肾脏疾病的无创分子影像学。
Nat Rev Nephrol. 2021 Oct;17(10):688-703. doi: 10.1038/s41581-021-00440-4. Epub 2021 Jun 29.
2
Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response.转移性肾细胞癌的系统治疗：扩散加权 MRI 的表观扩散系数在预测早期治疗反应中的作用。
Clin Exp Med. 2020 May;20(2):277-287. doi: 10.1007/s10238-020-00612-9. Epub 2020 Feb 5.
3
Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study.
基于 FLT-PET/MRI 的影像组学分析对肾癌早期治疗反应特征的初步研究
Transl Oncol. 2016 Apr;9(2):155-162. doi: 10.1016/j.tranon.2016.01.008.
4
¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.¹⁸F-FDG PET/CT用于监测乳腺癌的治疗反应
J Nucl Med. 2016 Feb;57 Suppl 1(Suppl 1):34S-9S. doi: 10.2967/jnumed.115.157875.